Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 7.8 to 1.8.
Financials
Financial year 2025
AMOPHAR from Schelle, company number BE0839385540, closed financial year 2025 with a result of € -138,093 after tax. For that financial year AMOPHAR recorded a gross margin of € 83,196 and equity of € -1 million. Compared with financial year 2024, the result moved from € -421,060 to € -138,093. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ -1 million
▼ € 138,093 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -138,093
▲ 67 % less loss than in 2024
Profit after tax over the fiscal year.
€ 10,513
▲ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1 million.
People and assets in 2025
1.8
▼ 4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 212,311
▼ 48% vs 2024
€ 118,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 694
▼ 79% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 122,303
▼ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,686
▼ 93% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 194,225 | € 528,318 | € 51,510 | € 83,196 | ▲ 62% |
| Profit after taxes | € -509,519 | € -153,338 | € -421,060 | € -138,093 | ▲ € 282,967 |
| Equity | € -305,308 | € -458,647 | € -879,706 | € -1,017,799 | ▼ € 138,093 |
| Total debts | € 1,216,184 | € 1,507,605 | € 1,314,145 | € 1,419,099 | ▲ 8% |
| Cash | € 41,573 | € 38,055 | € 8,609 | € 10,513 | ▲ 22% |
| Retained profit | € -325,308 | € -478,647 | € -899,706 | € -1,037,799 | ▼ € 138,093 |
| Balance sheet total | € 910,875 | € 1,048,958 | € 434,439 | € 401,301 | ▼ 8% |
| Employees (FTE) | 7.8 | 7.8 | 5.8 | 1.8 | ▼ 4 |
Key figures of AMOPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AMOPHAR?
What happened at AMOPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 138,093. Source: NBB ↗
- LBS Besloten Vennootschap became a director. NBB
- INPHAGRO Besloten Vennootschap became a director. NBB
- New establishment in Schelle. KBO
- Start of the company according to the CBE. KBO
In short
From € 509,519 loss in 2022 to € 138,093 loss in 2025.
Paid € 6,345 in corporate taxes since 2022.
On average € 46,200 of value added per employee in 2025.
A new publication or filing at AMOPHAR? We notify you, reason included.
Follow AMOPHARDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AMOPHAR are LBS Besloten Vennootschap and INPHAGRO Besloten Vennootschap. The shares are held by INPHAGRO.
Directors
According to the 2025 annual accounts
Director · represented by Asselman Lode
Also active at: L4P Invest, WOLFMAN, Amophar OTC, ALL-in-1
since 2020
INPHAGRO Besloten Vennootschap
Director · represented by Mc Cullough Sean
Also active at: LIFE MEDICAL, LIFE MEDICAL SOLUTIONS, FIDELMED, Protexx, Life International, Amophar OTC, ALL-in-1, KDT Consulting
since 2018
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Molenberglei 36
2627 Schelle
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →LIFE MEDICAL same network
€ 384,578 gross margin · 2025
INPHAGRO same network
€ 79,500 revenue · 2025
WOLFMAN same network
€ 126,568 gross margin · 2025
Amophar OTC same network
€ 4,288 gross margin · 2025
ALL-in-1 same network
€ 26.3 million revenue · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
GOOGLE-CLOUD-PLATFORM - Google LLC, US
DNS
GoDaddy DNS
Website info
Features
Security
Details
- Company number
- 0839.385.540
- VAT number
- BE 0839.385.540
- Registered office
- Molenberglei 36, 2627 Schelle
- Names & denominations
- AMOPHAR
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 September 2011
- Peppol
- Active · Active since 27 Mar 2026
- Contact
- allin-1.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen